Landmark Study Reveals the Promise of Infection-Free Medical Implantation is Near: Wayne Gattinella CEO DeBogy Molecular. Read what he has to say. https://t.co/WiASdcp152
Surgical #Implant Infections - Biotech startup @DeBogyHQ Molecular says its experimental tech could transform the surface of implants so bacteria won’t grow & cause infections in procedures such as knee & hip replacements | #surgery#infectioncontrol https://t.co/3aPABCBykc
Periprosthetic joint infections are recognized as a leading cause of morbidity and mortality in orthopaedic surgery. The results of the DeBogy in vivo study show unique promise to introduce a new solution to this recognized postoperative complication. https://t.co/iYiZ7Mb2Gl
The newest startup to join UConn’s Technology Incubation Program, @DeBogyHQ, is working to revolutionize the way we think about sterile surfaces at home, at work, and in health care settings.
https://t.co/fmVjI8OUWM
New @UConn Technology Incubation Program startup @DeBogyHQ developed technology that can render many materials permanently anti-viral, anti-bacterial, and anti-fungal without changing the look, shape, or feel of the original material.
https://t.co/hJlDvxAWvu @UConnTechComm